MedTrace Logo

Clinical Trial With PRECIZON Presbyopic

NCT02409771 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2017-04-04

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the effectiveness of the PRECIZON Presbyopic.

Conditions

Interventions

DEVICE

PRECIZON Presbyopic

Optical correction of aphakia in adults in whom the crystalline lens has been removed and who desire presbyopia correction.

Sponsors & Collaborators

  • Ophtec BV

    lead INDUSTRY

Principal Investigators

  • Mike P. Holzer, Prof. Dr. · Heidelberg University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-01-17
Completion
2017-01-17

Countries

  • Belgium
  • Germany
  • Netherlands
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02409771 on ClinicalTrials.gov